Condition
Specific Phobias
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed4
Suspended1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06906770Not ApplicableCompletedPrimary
Virtual Reality-based Eye Movement Desensitisation and Reprocessing Therapy for Specific Phobias
NCT06339463Not ApplicableSuspendedPrimary
Self-Distancing for Specific Phobia in Youth
NCT03095482Not ApplicableCompletedPrimary
tDCS-Augmented Exposure Therapy for Pathological Fear
NCT02605668Not ApplicableCompleted
Providing Tools for Effective Care and Treatment of Anxiety Disorders
NCT01849432Completed
Study of Brain Circuitry in Anxiety Disorders
Showing all 5 trials